Howard Hughes Medical Institute’s Visa V Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-364
| Closed | -$128K | – | 458 |
|
|
2025
Q4 | $128K | Sell |
364
-1
| -0.3% | -$341 | 0.07% | 14 |
|
|
2025
Q3 | $125K | Sell |
365
-7
| -2% | -$2.42K | 0.07% | 14 |
|
|
2025
Q2 | $132K | Buy |
+372
| New | +$130K | 0.05% | 14 |
|
|
2023
Q1 | – | Sell |
-40,000
| Closed | -$8.31M | – | 19 |
|
|
2022
Q4 | $8.31M | Sell |
40,000
-41,000
| -51% | -$8.27M | 4.63% | 9 |
|
|
2022
Q3 | $14.4M | Buy |
81,000
+41,000
| +103% | +$8.34M | 4.09% | 5 |
|
|
2022
Q2 | $7.88M | Hold |
40,000
| – | – | 4.26% | 12 |
|
|
2022
Q1 | $8.87M | Hold |
40,000
| – | – | 3.89% | 12 |
|
|
2021
Q4 | $8.67M | Hold |
40,000
| – | – | 3.4% | 13 |
|
|
2021
Q3 | $8.91M | Hold |
40,000
| – | – | 3% | 14 |
|
|
2021
Q2 | $9.35M | Hold |
40,000
| – | – | 3.13% | 14 |
|
|
2021
Q1 | $8.47M | Hold |
40,000
| – | – | 2.88% | 15 |
|
|
2020
Q4 | $8.75M | Hold |
40,000
| – | – | 2.05% | 15 |
|
|
2020
Q3 | $8M | Hold |
40,000
| – | – | 2.63% | 14 |
|
|
2020
Q2 | $7.73M | Hold |
40,000
| – | – | 3.15% | 11 |
|
|
2020
Q1 | $6.45M | Hold |
40,000
| – | – | 1.35% | 14 |
|
|
2019
Q4 | $7.52M | Sell |
40,000
-5,000
| -11% | -$901K | 2.69% | 9 |
|
|
2019
Q3 | $7.74M | Hold |
45,000
| – | – | 2.17% | 8 |
|
|
2019
Q2 | $7.81M | Hold |
45,000
| – | – | 3.74% | 7 |
|
|
2019
Q1 | $7.03M | Hold |
45,000
| – | – | 1.64% | 7 |
|
|
2018
Q4 | $5.94M | Hold |
45,000
| – | – | 1.88% | 12 |
|
|
2018
Q3 | $6.75M | Sell |
45,000
-10,000
| -18% | -$1.42M | 1.97% | 10 |
|
|
2018
Q2 | $7.29M | Hold |
55,000
| – | – | 1.84% | 9 |
|
|
2018
Q1 | $6.58M | Hold |
55,000
| – | – | 1.71% | 9 |
|
|
2017
Q4 | $6.27M | Hold |
55,000
| – | – | 1.63% | 10 |
|
|
2017
Q3 | $5.79M | Sell |
55,000
-99,813
| -64% | -$10.1M | 1.44% | 13 |
|
|
2017
Q2 | $14.5M | Buy |
154,813
+15,340
| +11% | +$1.42M | 2.65% | 6 |
|
|
2017
Q1 | $12.4M | Sell |
139,473
-14,510
| -9% | -$1.25M | 2.28% | 4 |
|
|
2016
Q4 | $12M | Sell |
153,983
-6,050
| -4% | -$486K | 2.74% | 3 |
|
|
2016
Q3 | $13.2M | Sell |
160,033
-19,207
| -11% | -$1.54M | 3.41% | 2 |
|
|
2016
Q2 | $13.3M | Buy |
179,240
+12,566
| +8% | +$984K | 4.47% | 1 |
|
|
2016
Q1 | $12.7M | Buy |
166,674
+139,101
| +504% | +$10.1M | 2.81% | 2 |
|
|
2015
Q4 | $2.14M | Sell |
27,573
-431
| -2% | -$33.4K | 0.33% | 45 |
|
|
2015
Q3 | $1.95M | Sell |
28,004
-1,444
| -5% | -$103K | 0.36% | 40 |
|
|
2015
Q2 | $1.98M | Sell |
29,448
-8,708
| -23% | -$590K | 0.42% | 47 |
|
|
2015
Q1 | $2.5M | Buy |
38,156
+3,544
| +10% | +$234K | 0.34% | 50 |
|
|
2014
Q4 | $2.27M | Buy |
34,612
+8,184
| +31% | +$493K | 0.61% | 46 |
|
|
2014
Q3 | $1.41M | Buy |
26,428
+12,472
| +89% | +$670K | 0.31% | 45 |
|
|
2014
Q2 | $735K | Buy |
13,956
+4,420
| +46% | +$231K | 0.12% | 47 |
|
|
2014
Q1 | $515K | Sell |
9,536
-1,508
| -14% | -$83.8K | 0.07% | 49 |
|
|
2013
Q4 | $615K | Sell |
11,044
-124
| -1% | -$6.25K | 0.09% | 49 |
|
|
2013
Q3 | $534K | Sell |
11,168
-336
| -3% | -$15.5K | 0.08% | 50 |
|
|
2013
Q2 | $526K | Buy |
+11,504
| New | +$503K | 0.17% | 55 |
|
Other funds holding V
VCM
VPM
Howard Hughes Medical Institute's V Position: Q1 2026 in Review
Howard Hughes Medical Institute sold out of Visa (V) in Q1 2026, closing a stake of 364 shares — an estimated $128K sold.
Howard Hughes Medical Institute first reported a position in V in Q2 2013 and held it in 42 quarters. The position peaked at $14.5M in Q2 2017. 4,451 funds tracked by Wall St. Rank hold V as of Q1 2026.
- Howard Hughes Medical Institute reported no remaining Visa position as of Q1 2026 after selling out during the quarter.
- Howard Hughes Medical Institute sold 364 Visa shares in Q1 2026, an estimated $128K.
- Howard Hughes Medical Institute first reported a position in Visa in Q2 2013 and held it in 42 quarters.
- Howard Hughes Medical Institute's Visa position peaked at $14.5M in Q2 2017.
- 4,451 funds tracked by Wall St. Rank held Visa as of Q1 2026.
Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.